CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS
Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D1 receptor agonist, and administering to the patient an effective amount of a dopamine D2...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FERNANDES, PRABHAVATHI, B POSTLETHWAIT, ROBERT, NEIL NICHOLS, DAVID, EARL MAILMAN, RICHARD, BERNARD |
| description | Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D1 receptor agonist, and administering to the patient an effective amount of a dopamine D2 receptor antagonist. Pharmaceutical compositions comprising a dopamine D1 receptor agonist and a dopamine D2 receptor antagonist are also described. The D1 dopamine receptor agonist and the D2 dopamine receptor antagonist can be administered to the patient in the same or in a different composition or compositions.
L'invention concerne des méthodes permettant de traiter un patient souffrant de troubles neurologiques, psychotiques et psychiatriques, qui consiste à administrer audit patient une quantité efficace d'un agoniste partiel et/ou total du récepteur D1 de la dopamine, et une quantité efficace d'un agoniste du récepteur D2 de la dopamine. L'invention concerne également des compositions pharmaceutiques comprenant un agoniste du récepteur D1 de la dopamine et un agoniste du récepteur D2 de la dopamine. Ces agonistes peuvent être administrés dans la même composition ou dans des compositions différentes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2005062894A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2005062894A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2005062894A23</originalsourceid><addsrcrecordid>eNrjZLBw9td1dPH19PMMDglyDPH091Pwd1Nw8Q9wBIq56ga5OrsGhPgHKTh5-rl4-rkrOPv7BviH-rkE8zCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-HB_IwMDUwMzIwtLE0cjY-JUAQAdNymk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS</title><source>esp@cenet</source><creator>FERNANDES, PRABHAVATHI, B ; POSTLETHWAIT, ROBERT, NEIL ; NICHOLS, DAVID, EARL ; MAILMAN, RICHARD, BERNARD</creator><creatorcontrib>FERNANDES, PRABHAVATHI, B ; POSTLETHWAIT, ROBERT, NEIL ; NICHOLS, DAVID, EARL ; MAILMAN, RICHARD, BERNARD</creatorcontrib><description>Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D1 receptor agonist, and administering to the patient an effective amount of a dopamine D2 receptor antagonist. Pharmaceutical compositions comprising a dopamine D1 receptor agonist and a dopamine D2 receptor antagonist are also described. The D1 dopamine receptor agonist and the D2 dopamine receptor antagonist can be administered to the patient in the same or in a different composition or compositions.
L'invention concerne des méthodes permettant de traiter un patient souffrant de troubles neurologiques, psychotiques et psychiatriques, qui consiste à administrer audit patient une quantité efficace d'un agoniste partiel et/ou total du récepteur D1 de la dopamine, et une quantité efficace d'un agoniste du récepteur D2 de la dopamine. L'invention concerne également des compositions pharmaceutiques comprenant un agoniste du récepteur D1 de la dopamine et un agoniste du récepteur D2 de la dopamine. Ces agonistes peuvent être administrés dans la même composition ou dans des compositions différentes.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050714&DB=EPODOC&CC=WO&NR=2005062894A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050714&DB=EPODOC&CC=WO&NR=2005062894A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FERNANDES, PRABHAVATHI, B</creatorcontrib><creatorcontrib>POSTLETHWAIT, ROBERT, NEIL</creatorcontrib><creatorcontrib>NICHOLS, DAVID, EARL</creatorcontrib><creatorcontrib>MAILMAN, RICHARD, BERNARD</creatorcontrib><title>CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS</title><description>Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D1 receptor agonist, and administering to the patient an effective amount of a dopamine D2 receptor antagonist. Pharmaceutical compositions comprising a dopamine D1 receptor agonist and a dopamine D2 receptor antagonist are also described. The D1 dopamine receptor agonist and the D2 dopamine receptor antagonist can be administered to the patient in the same or in a different composition or compositions.
L'invention concerne des méthodes permettant de traiter un patient souffrant de troubles neurologiques, psychotiques et psychiatriques, qui consiste à administrer audit patient une quantité efficace d'un agoniste partiel et/ou total du récepteur D1 de la dopamine, et une quantité efficace d'un agoniste du récepteur D2 de la dopamine. L'invention concerne également des compositions pharmaceutiques comprenant un agoniste du récepteur D1 de la dopamine et un agoniste du récepteur D2 de la dopamine. Ces agonistes peuvent être administrés dans la même composition ou dans des compositions différentes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBw9td1dPH19PMMDglyDPH091Pwd1Nw8Q9wBIq56ga5OrsGhPgHKTh5-rl4-rkrOPv7BviH-rkE8zCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-HB_IwMDUwMzIwtLE0cjY-JUAQAdNymk</recordid><startdate>20050714</startdate><enddate>20050714</enddate><creator>FERNANDES, PRABHAVATHI, B</creator><creator>POSTLETHWAIT, ROBERT, NEIL</creator><creator>NICHOLS, DAVID, EARL</creator><creator>MAILMAN, RICHARD, BERNARD</creator><scope>EVB</scope></search><sort><creationdate>20050714</creationdate><title>CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS</title><author>FERNANDES, PRABHAVATHI, B ; POSTLETHWAIT, ROBERT, NEIL ; NICHOLS, DAVID, EARL ; MAILMAN, RICHARD, BERNARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2005062894A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>FERNANDES, PRABHAVATHI, B</creatorcontrib><creatorcontrib>POSTLETHWAIT, ROBERT, NEIL</creatorcontrib><creatorcontrib>NICHOLS, DAVID, EARL</creatorcontrib><creatorcontrib>MAILMAN, RICHARD, BERNARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FERNANDES, PRABHAVATHI, B</au><au>POSTLETHWAIT, ROBERT, NEIL</au><au>NICHOLS, DAVID, EARL</au><au>MAILMAN, RICHARD, BERNARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS</title><date>2005-07-14</date><risdate>2005</risdate><abstract>Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D1 receptor agonist, and administering to the patient an effective amount of a dopamine D2 receptor antagonist. Pharmaceutical compositions comprising a dopamine D1 receptor agonist and a dopamine D2 receptor antagonist are also described. The D1 dopamine receptor agonist and the D2 dopamine receptor antagonist can be administered to the patient in the same or in a different composition or compositions.
L'invention concerne des méthodes permettant de traiter un patient souffrant de troubles neurologiques, psychotiques et psychiatriques, qui consiste à administrer audit patient une quantité efficace d'un agoniste partiel et/ou total du récepteur D1 de la dopamine, et une quantité efficace d'un agoniste du récepteur D2 de la dopamine. L'invention concerne également des compositions pharmaceutiques comprenant un agoniste du récepteur D1 de la dopamine et un agoniste du récepteur D2 de la dopamine. Ces agonistes peuvent être administrés dans la même composition ou dans des compositions différentes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2005062894A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | CO-ADMINISTRATION OF DOPAMINE-RECEPTOR BINDING COMPOUNDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T03%3A25%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FERNANDES,%20PRABHAVATHI,%20B&rft.date=2005-07-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2005062894A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |